Agomab Therapeutics NV

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Agomab Therapeutics NV
CIK #0002020932
EDGAR Form CIK 2011 - 2026
3 [0002020932]
6-K [0002020932]
SC 13D [0002020932]
SC 13G [0002020932]
Form 13D/13G Filer Form 13D/13G Subject Filed
Cormorant Asset Management LP Agomab Therapeutics NV [2026-05-15]
Redmile Group LLC Agomab Therapeutics NV [2026-05-15]
Sanofi Agomab Therapeutics NV [2026-05-06]
Pontifax Management 4 GP 2015 Ltd Agomab Therapeutics NV [2026-04-16]
FMR LLC Agomab Therapeutics NV [2026-03-06]
LSP 7 Cooperative UA Agomab Therapeutics NV [2026-02-17]
Form 3/4/5 Subject 2011 - 2026
Lefever Ellen
Agomab Therapeutics NV
Borderias Andrea Saez
van der Horst Paul Henryk
Verduyn-van Weegen Felice Isabel
Wiesel Philippe Constantin
Bond Colin Michael
Epstein David R
Hammer Ohad
Jahreis Angelika Martha
Kemula Pierre Thadee Victor
Knotnerus Tim Jasper
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com